Novavax completes enrolment in US trial of Covid-19 vaccine
Hello and welcome to the details of Novavax completes enrolment in US trial of Covid-19 vaccine and now with the details
Nevin Al Sukari – Sana'a – A small shopping basket filled with vials labelled ‘Covid-19 — Coronavirus Vaccine’ and medical sryinges are placed on a Novavax logo in this illustration taken November 29, 2020. — Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
NEW YORK, Feb 22 — Drug developer Novavax Inc said today it has completed patient enrolment in the late-stage study of its Covid-19 vaccine in the United States and Mexico.
The company said last month its vaccine was 89.3 per cent effective in preventing Covid-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the UK.
Novavax said it had enrolled 30,000 volunteers across the United States and Mexico.
In the late-stage trial, the company said 20 per cent of participants were Latinx, 13 per cent were African American, and 13 per cent were 65 and older. — Reuters
These were the details of the news Novavax completes enrolment in US trial of Covid-19 vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new. It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.